Screening for IDH mutations in chronic myelomonocytic leukemia.

about

Isocitrate dehydrogenase mutations in leukemia.

P2860

Q38133721-0BE52BE7-339C-41C6-AD84-F3655EB3AEA0

P2860

Screening for IDH mutations in chronic myelomonocytic leukemia.

Item

http://www.wikidata.org/entity/Q44179210

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Screening for IDH mutations in chronic myelomonocytic leukemia.

@en

Screening for IDH mutations in chronic myelomonocytic leukemia.

@nl

type

Item

label

Screening for IDH mutations in chronic myelomonocytic leukemia.

@en

Screening for IDH mutations in chronic myelomonocytic leukemia.

@nl

prefLabel

Screening for IDH mutations in chronic myelomonocytic leukemia.

@en

Screening for IDH mutations in chronic myelomonocytic leukemia.

@nl

P1476

Screening for IDH mutations in chronic myelomonocytic leukemia.

@en

P2093

Amparo Avaria

http://www.w3.org/2001/XMLSchema#string

Esperanza Such

http://www.w3.org/2001/XMLSchema#string

Guillermo F Sanz

http://www.w3.org/2001/XMLSchema#string

Inés Gómez-Seguí

http://www.w3.org/2001/XMLSchema#string

Irene Luna

http://www.w3.org/2001/XMLSchema#string

José Cervera

http://www.w3.org/2001/XMLSchema#string

M Leonor Senent

http://www.w3.org/2001/XMLSchema#string

Mariam Ibañez

http://www.w3.org/2001/XMLSchema#string

María López-Pavía

http://www.w3.org/2001/XMLSchema#string

Miguel A Sanz

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A.

Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia

Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms.

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.

P304

406-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2012.701295

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22906102

http://www.w3.org/2001/XMLSchema#string

Screening for IDH mutations in chronic myelomonocytic leukemia.

about

P2860

P2860

Screening for IDH mutations in chronic myelomonocytic leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698